ArticleJournal of Cancer2018

Addition of chemotherapy to intensity-modulated radiotherapy does not improve survival in stage II nasopharyngeal carcinoma patients.

Wang Fangzheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.